Latin America held a 3% share of the market in 2025 and is expected to grow at a significant CAGR of 14% during the projection period, driven by GLP-1 medications that are driving structural health and economic shifts across Latin America by curbing surging obesity and type-2 diabetes rates, spurring vast biopharma investments, and fundamentally changing consumer habits in the fast-moving consumer goods sector
We recommend the right option for each patient individually based on their health profile and goals
Genetic polymorphisms in glutathione S-transferases P1 (GSTP1) Ile105Val and prostate cancer risk: A systematic review and meta-analysis
Parks CG, Moe CL, Rhodes D, Lima A, Barrett L, Tseng F, Baric R, Talal AH, Guerrant R
The large majority of collagen types III and IV, and laminin are synthesized by HSCs and endothelial cells, whereas all cell types synthesize small amounts of collagen type I
Food & Healthcare Ingredients 2